Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03352232 · ClinicalTrials.gov registry record · Early Phase 1
Hyperbaric Oxygen and Manipulative Therapies to Regain Function Post Stroke
A Early Phase 1 study of Stroke and Ischemic Stroke, sponsored by Abington Memorial Hospital.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03352232: Completed Early Phase 1 study of Stroke and Ischemic Stroke, sponsored by Abington Memorial Hospital.
NCT03352232 is a Early Phase 1 study of Stroke and Ischemic Stroke that has completed, run by Abington Memorial Hospital. The registered enrollment target is 5 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03352232, a Early Phase 1 study of Stroke and Ischemic Stroke, has completed, sponsored by Abington Memorial Hospital.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
To study safety, feasibility and outcomes of combining osteopathic manipulative therapies with hyperbaric oxygen therapy in reducing the functional deficits in stroke survivors in subacute and chronic phases post ischemic stroke. To document the same as part of a pilot project in anticipation of further investigational studies.
Primary Outcome
Primary Outcome NIHSS 0-5, 0 without deficits; mRS 0-2, 0 without disability - 2 slight disability, no need for assistance
Conditions Studied
Interventions
- COMBINATION_PRODUCT HBOT and OMT
Study Locations (1)
Pennsylvania
- Abington Memorial Hospital - Abington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-02-03 |
| Est. Completion | 2021-07-19 |
| Phase | Early Phase 1 |
What the finished NCT03352232 record still lists
NCT03352232 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which HBOT and OMT is the first listed.
NCT03352232 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03352232 about?
NCT03352232 is a clinical study titled "Hyperbaric Oxygen and Manipulative Therapies to Regain Function Post Stroke". To study safety, feasibility and outcomes of combining osteopathic manipulative therapies with hyperbaric oxygen therapy in reducing the functional deficits in stroke survivors in subacute and chronic phases post ischemic stroke. To document the same as part of a pilot project in anticipation of fur...
What is the current status of trial NCT03352232?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2018-02-03. Estimated completion is 2021-07-19.
What conditions does trial NCT03352232 study?
This clinical trial studies the following conditions: Stroke, Ischemic Stroke, Chronic Stroke, Motor Dysfunction.
What interventions are being tested in trial NCT03352232?
The interventions under investigation include: HBOT and OMT (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03352232?
This trial is sponsored by Abington Memorial Hospital, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03352232 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03352232's enrollment target sits among peer trials
5 439th of 454 higher than 11 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Primed Stroke Rehabilitation
RECRUITING · Early Phase 1
-
R01.Aim 2.Study 1: IsoReach
RECRUITING · Early Phase 1
-
Effect of Neural Constraints on Movement in Stroke
RECRUITING · Early Phase 1
-
Multisensory Augmentation for Post-stroke Standing Balance
RECRUITING · Early Phase 1
-
Cognition and Motor Learning Post-stroke
RECRUITING · Early Phase 1
-
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI